Toxicogenomics and cancer pathogenesis
Journal Title: International Journal of Genetics - Year 2009, Vol 1, Issue 2
Abstract
Toxicogenomics is emerging field give idea of the application of large-scale differential gene expression data to toxicology, starting to influence drug discovery and development in the pharmaceutical industry. Its future potential in cancer pathogenesis, study of poisons and poisoning and has an ancient and venerable history. Toxicogenomics is the merging of toxicology with technologies that have been developed, together with bioinformatics, to identify and quantify global gene expression changes for gene therapy. Immunotoxic processes and the development of in vitro screening assays is therefore expected to be of value for mechanistic insight into immunotoxicity and hazard identification of existing and novel compounds. Successful application of toxicogenomic approaches, such as DNA microarrays, inextricably relies on appropriate data management, the ability to extract knowledge from massive amounts of data and the availability of functional information for data interpretation. Toxicogenomics is considered a valuable tool for reducing pharmaceutical candidate attrition by facilitating earlier identification, prediction and understanding of toxicities. Pharmaco-epidemiological (toxicogenomics) data is now available for both antiepileptic drugs, evidence for human carcinogenicity. Therapeutic researches converge triad of rejuvenation, regeneration or replacement strategies that rely on self-healing processes, stem cell regeneration organ transplantation. Metastases studies usually display more genetic changes than the primary tumour. Helix-loop-helix application in translational and functional toxicogenomics transcription factors has been implicated in diverse cellular processes such as proliferation, apoptosis, differentiation, and migration.
Authors and Affiliations
N. Gupta, G. Gupta, S. Trivedi, P. Patil, M. Gupta, A. Jhadav, K. K. Vamsi, Y. Khairnar, A. K. Mujapara, B. Joshi
Keywords
Related Articles
- EP ID EP170153
- DOI 10.9735/0975-2862.1.2.47-60
- Views 84
- Downloads 0
ISOLATION AND CHARACTERIZATION OF Proteus spp. FROM DOMESTIC DISPOSAL EXPRESSING EXTRACHROMOSOAL EXTENDED SPECTRUM β-LACTAMASE TRAIT
From a long time waterborne diseases have been major concern to living being. Handful countries have successfully implemented recycling of water. Recycling of water is under consideration in India. Indian rural region is...
Immunogenomics: recent discoveries
Immunogenomics is a new research field, which addresses the interface between host and (pathogen) proteome, bridging informatics technology, genomics, proteomics, immunology and clinical medicine. The switch from the par...
A NOVEL LMNA MUTATION IN TWO SOUTH INDIAN SIBLINGS WITH HUTCHINSON-GILFORD PROGERIA SYNDROME
Background: Hutchinson-Gilford progeria syndrome is a rare genetic disorder characterized by dramatic premature senescence. Progeria is almost always caused by de novo point mutations in the LMNA gene that activates a cr...
A STUDY OF INTERLEUKIN-15 (IL 15) GENE POLYMORPHISMS IN PAKISTANI PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
Background- Aim of the present study was to explore the association of two single nucleotide polymorphisms (SNPs), including rs4956403 (SNP-1) and rs3806798 (SNP-2) located in the 5’ UTR region of interleukin 15 gene i...
ADRA2A IS A CYSTIC FIBROSIS MODIFIER GENE
Background: Cystic fibrosis (CF) is an autosomal disease with characteristics of a complex disease. Understanding ADRA2A polymorphisms are important to elucidate clinical variability that is encountered in inflammatory d...